Writing a PhD thesis

By Sathya Muralidhar At the heart of the MELGEN consortium are the PhD students, who have been conducting melanoma research, as part of their PhD. There are many facets to a pursuing a PhD degree, conducting research actually being only one of many. For instance, sharing the findings fromRead More

ESR14 – Moving on to the next adventure

“If you are brave enough to say goodbye, life will reward you with a new hello!” – Paulo Coelho – Our ESR14 Sonia Leonardelli spun the Postdoc Fortune Wheel and took a chance! She hit the jackpot with a new job! Sonia recently has been awarded by the MildredRead More

Unite and Conquer Cancer

ASCO 2019 The ASCO (American Society of Clinical Oncology) organization provides an excellent platform for education of oncology professionals, promoting cancer research and advocating patients who suffer from cancer. Every year, the ASCO Annual Meeting takes place at the McCormick Place in Chicago, Illinois with the goal of conqueringRead More

First EACR-ESMO joint conference on Liquid Biopsies 2019 highlights

The first EACR-ESMO joint conference on Liquid Biopsies conference took place at the historic Centro Congressi Giovannia XXIII in Bergamo, Italy from 15-17 May 2019. I was delighted that I could attend my first liquid biopsy meeting ever, especially because I was one of the recipients of the EACR-WorldwideRead More

Helping. Researching. Informing.

Dr. Mildred Scheel was the founder of the Deutsche Krebshilfe (German Cancer Aid), which is Germany‚Äôs leading non-governmental funding and non-profit-making organization of oncology-related activities. The German Cancer Aid is based in Bonn and aims to promote innovative research and to educate and inform. Its motto is: “Helping. Researching.Read More

My secondment in Cambridge

My project involves Next Generation Sequencing (NGS) analysis of melanoma samples to understand resistance mechanisms to immunotherapy. Dr. Adams, who is one of the principal investigators of our Marie-Curie Ph.D. program based at the Wellcome Trust Sanger Institute in Cambridge, offered his help and expertise to perform the bioinformaticRead More

Immune system: our new fingerprint

In recent years, a considerable number of melanoma patients have shown great tumour regression when treated with immunotherapy agents. However, there is still a long way to go, when it comes to effectively select the patients that will actually benefit from these. My PhD project at Lund University, focusesRead More

Studying genetic changes in melanoma

Have you ever wondered why some melanoma patients do better than others? How is this linked to changes in our genes? In this video, I will highlight part of my research as a PhD student at the Wellcome Sanger Institute in Cambridge, UK.   To learn more, check outRead More